Research Article
Molecular Confirmation of Vancomycin-Resistant Staphylococcus aureus with vanA Gene from a Hospital in Kathmandu
Table 2
Antimicrobial susceptibility patterns of S. aureus isolates (n = 74).
| | Antimicrobial drugs | Sensitive, n (%) | Intermediate, n (%) | Resistant, n (%) |
| | Ampicillin | 11 (14.9) | 9 (12.2) | 54 (72.9) | | Cefoxitin | 29 (39.2) | 0 | 45 (60.8) | | Chloramphenicol | 24 (32.4) | 8 (10.8) | 42 (56.8) | | Ciprofloxacin | 22 (29.7) | 7 (9.5) | 45 (60.8) | | Clindamycin | 27 (36.5) | 6 (8.1) | 41 (55.4) | | Cotrimoxazole | 22 (29.7) | 5 (6.8) | 47 (63.5) | | Erythromycin | 13 (13.6) | 6 (8.1) | 55 (74.3) | | Gentamycin | 27 (36.5) | 5 (6.8) | 42 (56.7) | | Linezolid | 72 (97.3) | 0 | 2 (2.7) | | Oxacillin | 10 (13.5) | 0 | 64 (86.5) | | Penicillin | 8 (10.8) | 0 | 66 (89.2) | | Tetracycline | 18 (24.3) | 2 (2.7) | 54 (73.0) |
|
|
